Back
Akoya Biosciences Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
2
AKYA
Akoya Biosciences
Last Price:
2.12
Seasonality Move:
9.46%
7 Day Trial
ALL ACCESS PASS
$
7
Say this - unlock as much as $1,250 every Friday
Click here for full details.Akoya Biosciences Price Quote
$2.12
+0.01 (+0%)
(Updated: November 23, 2024 at 5:24 AM ET)
Akoya Biosciences Key Stats
Sell
2
Akoya Biosciences (AKYA)
is a Sell
Day range:
$2.11 - $2.21
52-week range:
$1.88 - $6.31
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.20
P/B ratio:
7.67%
Volume:
81.9K
Avg. volume:
159.1K
1-year change:
-49.16%
Market cap:
$104.6M
Revenue:
$96.6M
EPS:
$-1.18
How Much Does Akoya Biosciences Make?
-
How Much Are Akoya Biosciences's Sales Annually?
AKYA Revenues are $96.6M -
How Much Profit Does Akoya Biosciences's Make A Year?
AKYA net income is -$63.3M
Is Akoya Biosciences Growing As A Company?
-
What Is Akoya Biosciences's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.25% -
What Is Akoya Biosciences's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Akoya Biosciences Stock Price Performance
-
Did Akoya Biosciences Stock Go Up Last Month?
Akoya Biosciences share price went down by -26.48% last month -
Did AKYA's Share Price Rise Over The Last Year?
AKYA share price fell by -49.16% over the past 1 year
What Is Akoya Biosciences 52-Week High & Low?
-
What Is Akoya Biosciences’s 52-Week High Share Price?
Akoya Biosciences has traded as high as $6.31 over the past 52 weeks -
What Is Akoya Biosciences’s 52-Week Low Share Price?
Akoya Biosciences has traded as low as $1.88 over the past 52 weeks
Akoya Biosciences Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Akoya Biosciences?
-
How Much Debt Does Akoya Biosciences Have?
Total long term debt quarterly is $75.9M -
How Much Cash Does Akoya Biosciences Have?
Cash and short term investments quarterly total is $35.9M -
What Is Akoya Biosciences’s Book Value Per Share?
Book value per share is 0.28
Is Akoya Biosciences Cash Flow Positive?
-
What Is AKYA Cash Flow From Operations?
Cash flow from operations (TTM) is -$46.7M -
What Is Akoya Biosciences’s Cash Flow From Financing?
Cash flow from financing (TTM) is $8.4M -
What Is Akoya Biosciences’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$27.3M
Akoya Biosciences Return On Invested Capital
-
Is Management Doing A Good Job?
AKYA return on invested capital is -52.65% -
What Is Akoya Biosciences Return On Assets?
ROA measures how assets are converting to revenues and is -36.87% -
What Is AKYA Return On Equity?
ROE is a measure of profitability and is -157.22%
Akoya Biosciences Earnings Date & Stock Price
-
What Is Akoya Biosciences's Stock Price Today?
A single share of AKYA can be purchased today for 2.11 -
What Is Akoya Biosciences’s Stock Symbol?
Akoya Biosciences trades on the nasdaq under the ticker symbol: AKYA -
When Is Akoya Biosciences’s Next Earnings Date?
The next quarterly earnings date for Akoya Biosciences is scheduled on March 4, 2025 -
When Is AKYA's next ex-dividend date?
Akoya Biosciences's next ex-dividend date is November 25, 2024 -
How To Buy Akoya Biosciences Stock?
You can buy Akoya Biosciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Akoya Biosciences Competitors
-
Who Are Akoya Biosciences's Competitors?
Below is a list of companies who compete with Akoya Biosciences or are related in some way:
Akoya Biosciences Dividend Yield
-
What Is AKYA Dividend Yield?
Akoya Biosciences’s dividend yield currently is 0% -
What Is Akoya Biosciences’s Payout Ratio?
Akoya Biosciences’s payout ratio is 0% -
When Did Akoya Biosciences Last Pay A Dividend?
The latest dividend pay date is November 25, 2024 -
What Is Akoya Biosciences’s Dividend Per Share?
Akoya Biosciences pays a dividend of $0.00 per share
Akoya Biosciences Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 11.39% |
| Revenue: | -25.39% | -26% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 5 |
| Sell Recommendations: | 0 |
| Price Target: | 3.63 |
| Upside from Last Price: | 71.8% |